Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Assess whether a Total Market Fund Outperform SP 500 in Retirement by examining diversification, fees, and long-term performance to guide your strategy.
28,302 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Gold miners ETFs are in focus as 2026's rally tests the resilience of senior producers versus junior explorers. This ...
Morgan Stanley reports record revenue for 2025 and a solid Q4, but shares fall as liquidity constraints in private ma...
Mortgage rates sit above 6.6%, yet early 2026 data suggest the housing market still grow. This report breaks down wha...
As February 26 nears, ZachXBT unveils an upcoming insider trading report that traders expect to reshape crypto market...
A renewable-powered data-center company, Iren, surged after unveiling a multi-year Nvidia partnership and ambitious A...
JetBlue sparked attention by boosting its Q2 unit-revenue outlook, lifting airline sentiment and offering clues for t...
When a high-profile fan claims his courtside seats were pulled, it highlights the hidden costs, rules, and risk manag...
A public boundary moment evolves into a blueprint for guarding privacy, negotiating money, and building solid financi...
When allegations collide with privacy, financial planning and legal strategy collide too. This piece breaks down why ...
When a magnificent dividend stock drops 8%, it can feel painful. This guide shows how to separate price swings from l...
Rising AI chip costs and surging demand threaten to reshape consumer budgets, credit behavior, and retirement plannin...